|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1453504 |
USP |
Naltrexone 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1457006 |
USP |
Naphazoline Hydrochloride 200 mg |
|
469.33 CHF
510.16 €
|
|
|
|
USP-1457017 |
USP |
Naphazoline Related Compound A - (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide) 30 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1457083 |
USP |
Naphthalene 200 mg |
|
552.00 CHF
600.02 €
|
|
|
|
USP-1457301 |
USP |
Naproxen 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1457312 |
USP |
Naproxen Related Compound A (6-methoxy-2-naphthoic acid) 20 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1457356 |
USP |
Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate) 25 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1457403 |
USP |
Naproxen Sodium 200 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1457414 |
USP |
Naproxen Related Compound K - (1-(6-Methoxynaphthalen-2-yl)ethanol) 50 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1457425 |
USP |
Naproxen Related Compound L (1-(6-methoxynaphthalen-2-yl)ethanone) 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1457436 |
USP |
Naproxen Related Compound G - ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid) 50 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1457458 |
USP |
Narasin 125 mg |
|
644.00 CHF
700.03 €
|
|
|
|
USP-1457469 |
USP |
Naratriptan Hydrochloride 125 mg |
|
665.33 CHF
723.21 €
|
|
|
|
USP-1457491 |
USP |
Naratriptan Resolution Mixture 20 mg |
|
2,989.33 CHF
3,249.40 €
|
|
|
|
USP-1457505 |
USP |
Natamycin 200 mg |
|
456.00 CHF
495.67 €
|
|
|
|
USP-1457550 |
USP |
Naringin 200 mg |
|
682.67 CHF
742.06 €
|
|
|
|
USP-1457607 |
USP |
Nateglinide 200 mg |
|
469.33 CHF
510.16 €
|
|
|
|
USP-1457618 |
USP |
Nateglinide Related Compound A - trans-4-isopropylcyclohexanecarboxylic acid 10 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1457629 |
USP |
Nateglinide Related Compound B - N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine 10 mg |
|
873.33 CHF
949.31 €
|
|
|
|
USP-1457630 |
USP |
Nateglinide Related Compound C - N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine 20 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1457695 |
USP |
Negundoside ((1S,4aS,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-7-hydroxy-1-{[2-O-(4-hydroxybenzoyl)-beta-Dglucopyranosyl]oxy}-7-methylcyclopenta[c]pyran-4-carboxylic acid) 50 mg |
|
429.33 CHF
466.68 €
|
|
|
|
USP-1457709 |
USP |
Vitex negundo Leaf Dry Extract 3 g |
|
429.33 CHF
466.68 €
|
|
|
|
USP-1457797 |
USP |
Nebivolol Stereoisomer Mixture 15 mg |
|
1,514.67 CHF
1,646.45 €
|
|
|
|
USP-1457833 |
USP |
Nebivolol Hydrochloride 150 mg |
|
2,697.33 CHF
2,932.00 €
|
|
|
|
USP-1457844 |
USP |
Near IR System Suitability 1 unit |
|
2,737.33 CHF
2,975.48 €
|
|
|
|
USP-1457855 |
USP |
Nebivolol Related Compound A - A mixture of (S)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol Hydrochloride, (R,1S,1'S)-2,2'-Azanediylbis{1-[(R)-6-fluorochroman-2-yl]ethanol} Hydrochloride and (S,1R,1'R)-2,2'-Azanediylbis{1-[(S)- 6-fluorochroman-2-yl]ethanol} Hydrochloride 30 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1457866 |
USP |
Nebivolol Related Compound B - A mixture of (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride, (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(R)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride and (S)-1-[(S)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride 30 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1457877 |
USP |
Nebivolol Related Compound C (COLD SHIPMENT REQUIRED) - ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) 100 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1457888 |
USP |
Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) 100 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1457899 |
USP |
Nebivolol Related Compound E - (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) 30 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1457902 |
USP |
Nefazodone Hydrochloride (HCl) 200 mg |
|
1,246.67 CHF
1,355.13 €
|
|
|
|
USP-1457913 |
USP |
Nefazodone Related Compound A - 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride 25 mg |
|
842.67 CHF
915.98 €
|
|
|
|
USP-1457924 |
USP |
Nefazodone Related Compound B - 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride 25 mg |
|
842.67 CHF
915.98 €
|
|
|
|
USP-1458009 |
USP |
Neomycin Sulfate - Biologic 200 mg |
|
485.33 CHF
527.55 €
|
|
|
|
USP-1458019 |
USP |
Neomycin B ((2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-beta-Lidopyranosyl)-beta-D-ribofuranosyl]-D-streptamine sulfate) - Biologic - BACKORDER 150 mg |
|
510.67 CHF
555.10 €
|
|
|
|
USP-1458020 |
USP |
Neomycin A 2,5 mg |
|
733.33 CHF
797.13 €
|
|
|
|
USP-1458031 |
USP |
Neomycin Sulfate System Suitability Mixture - Biologic 100 mg |
|
549.33 CHF
597.12 €
|
|
|
|
USP-1458042 |
USP |
Neohesperidin (30 mg) - (S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside 30 mg |
|
1,098.67 CHF
1,194.25 €
|
|
|
|
USP-1458064 |
USP |
Neodiosmin (5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-Dglucopyranoside) 30 mg |
|
509.33 CHF
553.64 €
|
|
|
|
USP-1458086 |
USP |
Neohesperidin Dihydrochalcone (3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-O-(alpha-L-rhamnopyranosyl)-Beta-D-glucopyranoside) 500 mg |
|
600.00 CHF
652.20 €
|
|
|
|
USP-1459001 |
USP |
Neostigmine Bromide 200 mg |
|
313.33 CHF
340.59 €
|
|
|
|
USP-1460000 |
USP |
Neostigmine Methylsulfate ((m-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamate) 200 mg |
|
474.67 CHF
515.97 €
|
|
|
|
USP-1460010 |
USP |
Neostigmine Related Compound A (3-Hydroxy-N,N,N-trimethylbenzenaminium bromide) 15 mg |
|
1,302.67 CHF
1,416.00 €
|
|
|
|
USP-1460021 |
USP |
Neostigmine Related Compound B (3-(Dimethylamino)phenol) 15 mg |
|
1,006.67 CHF
1,094.25 €
|
|
|
|
USP-1460032 |
USP |
Neostigmine Related Compound C (3-(Dimethylamino)phenyl dimethylcarbamate) 15 mg |
|
1,302.67 CHF
1,416.00 €
|
|
|
|
USP-1460204 |
USP |
Neotame - BACKORDER 200 mg |
|
512.00 CHF
556.54 €
|
|
|
|
USP-1460215 |
USP |
Neotame Related Compound A - N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 15 mg |
|
1,574.67 CHF
1,711.67 €
|
|
|
|
USP-1460317 |
USP |
Nepafenac 200 mg |
|
781.33 CHF
849.31 €
|
|
|
|
USP-1460328 |
USP |
Nepafenac Related Compound A (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide) 25 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1460339 |
USP |
Nepafenac Related Compound B (7-Benzoylindolin-2-one) 25 mg |
|
1,372.00 CHF
1,491.36 €
|
|
